Non-random primary and secondary chromosomal abnormalities in human gastric cancers

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 1787-1795

  Yadav, Maneesha ^a   Hopwood, Vicki L ^a   Multani, Asha S ^a   Mansfield, Paul F ^a   Takahashi, Yutaka ^a   Mcintyre, Bradley W ^a   Udagawa, Taturo ^a   Pathak, Sen ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cytogenetics; Fluorescence in situ hybridization (FISH); Gastric cancer; Histopathology; Karyotype

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CASE REPORT; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 13; CHROMOSOME 15; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 19; CHROMOSOME 22; CHROMOSOME 3; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; STOMACH CANCER; STRUCTURAL CHROMOSOME ABERRATION; X CHROMOSOME;

BIOPSY; CARCINOMA; CARCINOMA, SIGNET RING CELL; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DISORDERS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; HUMANS; KARYOTYPING; MALE; MUTATION; NEOPLASM STAGING; PROTO-ONCOGENES; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; X CHROMOSOME;

EID: 0029758724     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. American Cancer Society (ACS): Cancer facts and figures, 1995.
2. van der Riet-Fox MF, Retief AE and van Niekerk WA: Chromosome changes in 17 human neoplasms studied with handing. Cancer 44: 2108-2119, 1979.
3. Ochi H, Douglass, Jr., H0 and Sandberg AA: Cytogenetic studies in primary gastric cancer. Cancer Genet Cytogenet 22: 295-307, 1986.
4. Rao PH, Mathew S, Kelsen DP and Chaganti RSK: Cytogenetics of gastric and esophageal adenocarcinomas: 3q deletion as a possible primary chromosomal change. Cancer Genet Cytogenet 81: 139-143, 1995.
5. Udagawa T, Hopwood VL, Pathak S and McIntyre BW: Integrin-mediated entry into S phase of human gastric adenocarcinoma cells. Clin Exp Metastasis 13: 427-438, 1995.
6. Asai T: Establishment and characterization of human undifferentiated carcinoma cell line of the stomach (KKLS), and a trial of new chemosensitivity test, liquid top layer - MTT assay (LMA). J Juzesa Med Soc 100: 1-17, 1991.
7. Pathak S: Chromosome banding techniques. J Reprod Med 17: 25-28, 1976.
8. Whang Peng J, Knutsen T, Gazdare A, Steinberg SM, Oie H, Linnoila I,Mulshine J, Nau M and Minna JD: Non-random structural and numerical chromosome changes in non-small cell lung cancer. Genes Chromosome Cancer 3: 168-188, 1991.
9. Pathak S, Strong LC, Ferrell RE and Trindade A: Familial renal cell carcinoma with a 3,11 chromosome translocation limited to tumor cells. Science 217: 939-941, 1982.
10. Pandis N, Jin Y, Limon J, Bardi G, Idvall I. Mandahl N, Mitelman F and Heim S: Interstitial deletion of the short arm of chromosome 3 as a primary chromosome abnormality in carcinomas of the breast. Genes Chromosome Cancer 6: 151-155, 1993.
11. Pejovic T, Heim S, Mandahl N, Baldetorp B, Elmfors B, Folderus UM, Furgyik S, Helm G, Himmelmann A, Willen H and Mitelman F: Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosome Cancer 4: 58-68, 1992.
12. Dave BJ, Hsu TC, Hong WK and Pathak S: Non-random distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies. Int J Oncol 5: 733-740, 1994.
13. Yokoyama S, Yamakawa K, Tsuchiya E, Murata S, Sakiyama S and Nakamura Y: Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 52: 873-877, 1992.
14. Sanchez Y, El-Naggar A, Pathak S and Killary AM: A tumor suppressor locus within 3p14-p12 mediates rapid cell death of renal cell carcinoma in vitro. Proc Natl Acad Sci USA 91: 3383-3387, 1994.
15. Rodriguez E, Rao PH, Landanyi M, Altorki N, Albino AP, Kelsen DP, Jhanwar SC and Chaganti RSK: 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas. Cancer Res 50: 6410-6414, 1990.
16. Xiao S, Geng J-S, Feng X-L, Liu X-Q, Liu Q-X and Li AP: Cytogenetic studies of eight primary gastric carcinomas. Cancer Genet Cytogenet 58: 79-84, 1992.
17. Bullerdiek J, Bartnitzke S, Kahrs E and Schloot W: Further evidence for non-random chromosome changes in carcinoma cells. A report of 28 cases. Cancer Genet Cytogenet 16: 33-43, 1985.
18. Seruca R, Constancia M, Santos NRD, David L, Queimado L, Carvalho F and Carneiro F: Allele loss in human gastric carcinomas: Relation to tumor progression and differentiation. Int J Oncol 7: 1159-1166, 1995.
19. Seruca R, Castedo S, Correia C, Gomes P, Carneiro F, Soares P, de Jong B and Sobrinho-Somoes B: Cytogenetic findings in eleven gastric carcinomas. Cancer Genet Cytogenet 68: 42-48, 1993.
20. Satya-Prakash KL, Pathak S, Hsu TC, Olive M and Cailleau R: Cytogenetic analysis on eight human breast tumor cell lines: high frequencies of 1q, 11q and HeLa-like marker chromosomes. Cancer Genet Cytogenet 3: 61-73, 1981.
21. Koufos A, Hansen MF, Copeland NG, Jenkins NA, Lampkin BC and Cavenee WK: Loss of heterozygosity in three embryonal tumors suggests a common pathogenic mechanism. Nature 316: 300-334, 1985.
22. Fcaron ER, Feinberg AP, Hamilton SH and Vogelstein B: Loss of genes on the short arm of chromosome 11 in bladder cancer. Nature 318: 377-380, 1985.
23. Pathak S: Cytogenetics of epithelial malignancies. Cancer 70: 1660-1670, 1992.
24. Dave BJ, Hopwood VL, Spitz MR and Pathak S: Sex chromosome abnormalities in lung cancer patients. Cancer Genet Cytogenet 81: 1-5, 1995.
25. Nowinski GP, van Dyke DL, Tilley BC, Jacobsen G, Babu VR, Worsham MJ, Wilson GN and Weiss L: The frequency of aneuploidy in cultured lymphocytes is correlated with age and gender but not with reproductive history. Am J Hum Genet 46: 1101-1111, 1990.
26. Pathak S, Hopwood VL, Babaian RJ, Logothetis CJ and von Eschenbach AC: Chromosome alterations in human prostate cancer: evidence for specific anomalies in lymphocyte cultures. (Abstract #946). American Urological Association, Inc., Annual Meeting, San Antonio, TX, 1993.
27. Pettaway CA, Greene G, Pathak S, Beilenberg D, Ramirez E, Multani AS, Wilson M, Killion JJ and Fidler IJ: Selection of highly metastatic variants of human prostatic carcinomas (Pc-3M, LNCaP) utilizing orthotopic implantation in nude mice (submitted).
28. Pathak S: Cytogenetic abnormalities in Cancer: with special emphasis on tumor heterogeneity. Cancer Metastasis Rev 8: 299-318, 1990.
29. Pathak S, Staroselsky AH and Fidler IJ: Specific chromosomal defects associated with metastatic potential in K-1735 melanoma clones: Involvement of chromosomes 4 and 14. Cancer Genet Cytogenet 56: 209-221, 1991 .
30. Yanagihara K, Seyama T, Tsumuraya M, Kamada N and Yokoro K: Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 51: 381-386, 1991 .
31. Tahara E: Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 119: 265-272, 1993.
32. Tohdo H, Yokozaki H, Haruma K, Kajiyama G and Tahara E: p53 gene mutations in gastric adenomas. Virchows Arch 63: 191-195, 1993.
33. Nishimura K, Yokozaki H, Haruma K, Kajiyama G and Tahara E: Alterations of the APC gene in carcinoma cell lines and precancerous lesions of the stomach. Int J Oncol 7: 587-592, 1995.
34. Nakatsuru S, Yanagisawa A, Ichii S, Tahara E, Kato Y, Nakamura Y and Horci A: Somatic mutation of the APC gene in gastric cancer: frequent mutation in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1: 559-563, 1992.
35. Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kahayashi M, Sugimura T and Hirohashi S: Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 52: 3099-3102, 1992.
36. Hockenherry D, Nunez G, Milliman C, Schreiber RD and Korsmeyer SJ: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990.
37. Tahara E: Carcinogenesis and progression of human gastric cancer. Trans Soc Pathol Jpn 81: 21-49, 1992.
38. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H and Tahara E: Frequent amplification of the c-met gene in scirrhous-type stomach cancer. Biochem Biophys Res Commun 189: 227-232, 1992.
39. Hattori Y, Odagiri H, Nakatani H, Miyagawa K, Naito K, Sakanoto H, Katoh O, Yoshida T, Sugimura T and Terada M: K-sani, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci USA 87: 5983-5987, 1990.
40. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGRath J, Seehurg PH, Libermann TA, Schlessinger J and Francke U: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230: 1132-1139, 1985.
41. Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M, Tahara E: Expression of TGF-heta and procollagen type I and type III in human gastric carcinomas. Int J Cancer 44: 394-398, 1989.
42. Tsuda T, Yoshida K, Tsujino T, Naskayama H, Kajiyama G and Tahara E: Coexpression of platelet-derived growth factor (PDGF) A-chain and PDGF receptor genes in human gastric carcinomas. Jpn J Cancer Res 80: 813-817, 1989.
43. Tahara E: Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 116: 121-131, 1990.
44. Tanimoto H, Yosida K, Kokozaki H, Yasui W, Nakayama H, Ito H, Ohama K and Tahara E: Expression of basic fibroblast growth factor in human gastric carcinomas. Virchows Arch 61: 263-267. 1991.